CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop innovative nanocarriers for targeted cancer therapy, addressing challenges like toxicity and poor drug delivery. By creating biodegradable and biocompatible nanocarriers that work alongside radiation treatment, it seeks to enhance the effectiveness of cancer treatments while minimizing side…
Currently, cancer is the second cause of morbidity and death in Europe, with 1.9m deaths and 3.7m cases annually.
Cancer-related deaths are projected to exceed 13m by 2030, with abdominal organs hosting most cancer incidents.
Although popular, conventional modalities are nonetheless associated with major clinical challenges such as non-specificity, side effects, and drug tolerance, which impede further developments.
In recent years, non-invasive, controllable, minimal side effects, and localized…
UNIVERSITY OF GALWAY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Ireland, Dublin
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
